77 related articles for article (PubMed ID: 7025257)
1. The effects of labetalol and oxprenolol on blood lipids.
Sommers DK; de Villiers LS; van Wyk M; Schoeman HS
S Afr Med J; 1981 Sep; 60(10):379-80. PubMed ID: 7025257
[TBL] [Abstract][Full Text] [Related]
2. The effect on HDL cholesterol of oxprenolol and atenolol.
Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic mechanisms in control of plasma lipid concentrations.
Day JL; Metcalfe J; Simpson CN
Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
[TBL] [Abstract][Full Text] [Related]
4. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
Johnson BF; LaBrooy J; Munro-Faure AD
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
[TBL] [Abstract][Full Text] [Related]
5. Changes in butyrylcholinesterase activity and serum lipids after oxprenolol and glibenclamide treatments in non-diabetic rats.
Bradamante V; Krnić Z; Zrinski R; Konjevoda P; Reiner Z
Arzneimittelforschung; 2006; 56(2):64-9. PubMed ID: 16572919
[TBL] [Abstract][Full Text] [Related]
6. Labetalol and lipids.
McGonigle RJ; Williams L; Murphy MJ; Parsons V
Lancet; 1981 Jan; 1(8212):163. PubMed ID: 6109848
[No Abstract] [Full Text] [Related]
7. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
Johnson BF; LaBrooy J; Munro-Faure AD
Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
[TBL] [Abstract][Full Text] [Related]
8. Dose and duration effects of estradiol valerate on serum and lipoprotein lipids.
Enk L; Crona N; Samsioe G; Silfverstolpe G
Horm Metab Res; 1986 Aug; 18(8):551-4. PubMed ID: 3530933
[TBL] [Abstract][Full Text] [Related]
9. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
[TBL] [Abstract][Full Text] [Related]
10. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxprenolol treatment on pseudocholinesterase and lipids in rats.
Krnić Z; Bradamante V
Arzneimittelforschung; 1997 Aug; 47(8):910-3. PubMed ID: 9296276
[TBL] [Abstract][Full Text] [Related]
12. Effect of carnitine on serum HDL-cholesterol: report of two cases.
Rossi CS; Siliprandi N
Johns Hopkins Med J; 1982 Feb; 150(2):51-4. PubMed ID: 7057619
[TBL] [Abstract][Full Text] [Related]
13. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
[TBL] [Abstract][Full Text] [Related]
14. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
16. Effect of mepindolol on serum lipids.
Martignoni A; Perani G; Finardi G; Mastropasqua E; Fogari R
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):543-5. PubMed ID: 7174157
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive therapy and the risk of coronary heart disease.
Ames RP; Hill P
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
[TBL] [Abstract][Full Text] [Related]
18. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of a purified bran preparation in men with low HDL cholesterol.
Lithell H; Selinus I; Vessby B
Hum Nutr Clin Nutr; 1984 Jul; 38(4):309-13. PubMed ID: 6088439
[TBL] [Abstract][Full Text] [Related]
20. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
